| Chair | 
            Hiroyuki Mano (The Univ. of Tokyo / Natl. Cancer Ctr. Res. Inst.) | 
          
          
            | Members | 
            Hirotoshi Akita (Hokkaido Univ.) | 
          
          
            |   | 
            Tetsu Akiyama (Inst. of Mol. & Cell. Biosci., The Univ. of Tokyo) | 
          
          
            |   | 
            Hiroyuki Aburatani (Res. Ctr. for Advanced Sci. & Tech., The Univ. of Tokyo) | 
          
          
            |   | 
            Chikashi Ishioka (Inst. of Development, Aging & Cancer, Tohoku Univ.) | 
          
          
            |   | 
            Fuyuki Ishikawa (Kyoto Univ.) | 
          
          
            |   | 
            Hidenori Ichijo (The Univ. of Tokyo) | 
          
          
            |   | 
            Johji Inazawa (Med. Res. Inst., Tokyo Med. & Dent. Univ.) | 
          
          
            |   | 
            Takeshi Imamura (Ehime Univ.) | 
          
          
            |   | 
            Masanobu Oshima (Cancer Res. Inst. of Kanazawa Univ.) | 
          
          
            |   | 
            Atsushi Ohtsu (Exploratory Oncology Res. & Clin. Trial Ctr., Natl. Cancer Ctr.) | 
          
          
            |   | 
            Hiroyuki Osada (Chemical Genetics Lab., RIKEN) | 
          
          
            |   | 
            Atsushi Ochiai (Natl. Cancer Ctr. Res. Inst.) | 
          
          
            |   | 
            Yutaka Kawakami (Keio Univ. Sch. of Med.) | 
          
          
            |   | 
            Mitsuyasu Kato (Univ. of Tsukuba) | 
          
          
            |   | 
            Mari Kannagi (Tokyo Med. & Dent. Univ.) | 
          
          
            |   | 
            Akira Kikuchi (Osaka Univ.) | 
          
          
            |   | 
            Issay Kitabayashi (Natl. Cancer Ctr. Res. Inst.) | 
          
          
            |   | 
            Yutaka Kondo (Nagoya City Univ.) | 
          
          
            |   | 
            Hideyuki Saya (Keio Univ. Sch. of Med.) | 
          
          
            |   | 
            Tatsuhiro Shibata (The  Inst. of Med. Sci., The Univ. of Tokyo) | 
          
          
            |   | 
            Hiroki Shirato (Hokkaido Univ.) | 
          
          
            |   | 
            Akira Suzuki (Kobe Univ.) | 
          
          
            |   | 
            Hiromu Suzuki (Sapporo Med. Univ.) | 
          
          
            |   | 
            Hiroyuki Seimiya (Cancer Chemother. Ctr., Japanese Foundation for Cancer Res.) | 
          
          
            |   | 
            Nobuyuki Takakura (Res. Inst. for Microbial Diseases, Osaka Univ.) | 
          
          
            |   | 
            Junko Takita (The Univ. of Tokyo) | 
          
          
            |   | 
            Shun'ichiro Taniguchi (Shinshu Univ.) | 
          
          
            |   | 
            Hidetoshi Tahara (Hiroshima Univ.) | 
          
          
            |   | 
            Shigeru Chiba (Univ. of Tsukuba) | 
          
          
            |   | 
            Tomoki Todo (The Inst. of Med. Sci., The Univ. of Tokyo) | 
          
          
            |   | 
            Hidewaki Nakagawa (Ctr. for Genomic Med., RIKEN) | 
          
          
            |   | 
            Takuro Nakamura (Japanese Foundation for Cancer Res.) | 
          
          
            |   | 
            Yasuharu Nishimura (Kumamoto Univ.) | 
          
          
            |   | 
            Eiji Hara (Res. Inst. for Microbial Diseases, Osaka Univ.) | 
          
          
            |   | 
            Okio Hino (Juntendo Univ.) | 
          
          
            |   | 
            Naoya Fujita (Cancer Chemother. Ctr., Japanese Foundation for Cancer Res.) | 
          
          
            |   | 
            Yoichi Furukawa (The Inst. of Med. Sci., The Univ. of Tokyo) | 
          
          
            |   | 
            Yoshio Miki (Tokyo Med. & Dent. Univ.) | 
          
          
            |   | 
            Satoru Miyano (The Inst. of Med. Sci., The Univ. of Tokyo) | 
          
          
            |   | 
            Yoshinori Murakami (The Inst. of Med. Sci., The Univ. of Tokyo) | 
          
          
            |   | 
            Yasuhiro Matsumura (Exploratory Oncology Res. & Clin. Trial Ctr., Natl. Cancer Ctr.) | 
          
          
            |   | 
            Hozumi Motohashi (Inst. of Development, Aging & Cancer, Tohoku Univ.) | 
          
          
            |   | 
            Keitaro Matsuo (Aichi Cancer Ctr. Res. Inst.) | 
          
          
            |   | 
            Masaki Mori (Osaka Univ.) | 
          
          
            |   | 
            Wataru Yasui (Hiroshima Univ.) | 
          
          
            |   | 
            Seiji Yano (Cancer Res. Inst. of Kanazawa Univ.) | 
          
          
            |   | 
            Tesshi Yamada (Natl. Cancer Ctr. Res. Inst.) | 
          
          
            |   | 
            Yasuhiro Yamada (Kyoto Univ.) | 
          
          
            |   | 
            Minoru Yoshida (Chemical Genetics Lab., RIKEN) |